Auriga maintains a 'Buy' on United Therapeutics (Nasdaq: UTHR), names stock as Best 2010 Biotechnology Idea. Price target increased from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE